Americas Dominating Dental Industry Market

Market Highlights

The dental industry includes the diagnosis, treatment, instruments, and devices related to oral health. There are various problems related to oral health such as pigmentation in gums, teeth cavity, brown or discoloration of teeth and others which are treated under the dental, medical industry. The key factors driving the dental industry include rising aging population globally, growing demand for cosmetic dentistry treatments, and increasing demand for dental procedures.

However, factors such as low dental insurance coverage compared to general health, lack of technological awareness and grey market of dental products, hinder the market growth. The market for the global Dental Industry Market is estimated to grow at an approximate CAGR of 7.6% from 2018 to 2023.
Key Players

Henry Schein Inc., Hu-Friedy Mfg Co., Ivoclar Vivadent AG, Nakanishi Inc., Patterson Companies Inc., Dentsply Sirona, Ultradent Products Inc., Young Innovations Inc., and 3M Company, Zimmer Biomet, Kangda Medical are some of the major players for global dental industry market.

Segmentation

·         The global dental industry market is segmented on the basis of discipline, consumables and end users.

·         On the basis of the discipline, the market is categorized into restorative dentistry, endodontics, prosthodontics, orthodontics, periodontics, and oral surgery.

·         On the basis of consumables, the global dental industry market is segmented into dental burs, whitening material, dental biomaterial, gingival retraction material, dental anesthetic, dental syringe, and endodontic supplies. The dental biomaterial segment is sub-segmented into dental cement, dental bone graft and regenerative tissue material. The gingival retraction material is further sub-segmented into gingival hemostatic agents, gingival retraction cord and gingival retraction paste/gels/cap. The dental anesthetic is further sub-segmented into topical anesthetics, injectable anesthetic, and non-injectable anesthetic.

·         On a regional basis, the global dental industry market in the Americas is segmented into two major regions, i.e., North America and Latin America.

Regional Analysis

The Americas dominate the global dental industry market owing to the increasing prevalence of fungal infection in the mouth, growing demand for cosmetic dentistry treatments and a huge patient population suffering from oral diseases across the Americas. According to the Centers for Disease Control and Prevention the US oral and dental health data 84.6% of children aged 2-17 years have a dental visit in the US in 2016 which increase the dental industry in this region.

Moreover, rising healthcare expenditure and the presence of developed economies like the US and Canada fuel the market growth.

Europe is second in the global dental industry market owing to a huge number of children’s suffering oral problems, increasing geriatric population, and presence of the developed economies like the UK, Italy, France, and others.  Asia-Pacific region is the fastest growing market owing to the presence of developing economies, a growing healthcare sector and rising geriatric population drive the market with the region. The Middle East & Africa has the least share in the global dental industry market owing to the presence of poor economies and stringent government policies, especially in the African region.

Q Fever Market Strengths, Global Dynamics and Forecast to 2023

Market Overview:

Q fever is a bacterial disease caused by the Coxiella burnetii bacterium. It usually manifests in flu-like symptoms and is fairly easy to treat. However, in a small percentage of patients, Q fever may present as a chronic disease. This chronic version of the disease can be much more dangerous, with potential implications for the patient’s cardiovascular system and the possible contraction of pneumonia, hepatitis, and encephalitis. The chronic version of Q fever is thus more feared and is the reason why considerable expenses have been made to counter the condition.

The global Q Fever Market is expected to exhibit a strong 7.83% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR). The global Q fever market is thoroughly analyzed in the report in order to provide readers with a complete overview of the market’s major drivers and restraining factors, as well as the economic background of the market and the competitive landscape of the market. The global Q fever market is expected to reach a valuation of more than USD 6.2 million by 2023.

The effect of Q fever infection is mostly chronic however few cases may become acute. Some of the complications include encephalitis, hepatitis, splenomegaly, endocarditis and pneumonia. In acute q fever, hospitalization is highly likely. 

Competitive Analysis:

·         AtoxBio

·         Yashica Pharmaceuticals

·         Johnson & Johnson Services Inc

·         Bayer AG

·         Melinta Therapeutics Inc

·         Sanofi SA

·         Basilea Pharmaceutica Ltd

·         Pfizer Inc

·         Teva Pharmaceutical

·         Merck KGaA

Segmentation:

·         The global Q fever market is segmented on the basis of type, diagnosis, treatment, end use, and region.

·         By type, the global Q fever market is segmented into acute and chronic. The chronic Q fever segment is the leading revenue generator and is likely to exhibit the higher CAGR over the forecast period.

·         By diagnosis, the Q fever market is segmented into serology tests and others.

·         By treatment, the global Q fever market is segmented into antibiotics and surgery. Surgery dominates the global Q fever market by treatment type, as it is a crucial accessory to treating chronic Q fever, where the damage may have spread to other organ systems in the body.

·         By end use, the global Q fever market is segmented into patients, hospitals and clinics, and others. The patients segment held a dominant share of more than 72% in the global Q fever market in 2017.

Regional Analysis:

Asia Pacific, Americas (North America and South America), Europe are among the key regions covered in MRFR’s analysis. Asia Pacific is the largest market for q fever. In 2017, APAC accounted for 44.5% share of the global Q fever market in terms of revenue and is projected to capture 8.57% CAGR during the assessment period. High prevalence of bacterial infection, and high risk of epidemic developing countries in the region makes q fever a prudent disease in APAC. China and India have emerged as the two most significant markets for q fever in APAC. In addition, governments in these countries are increasing their focus on improving healthcare services as well as undertaking initiatives to spread awareness.

After Asia Pacific, the Q fever market is most attractive in Europe and North America. This is mainly due to factors such as high healthcare expenditure, high level of awareness and strong healthcare penetration. Prevalence of animal-transmitted diseases in these regions is moderate owing to existence of robust precautionary measures

Hemostasis and Tissue Sealing Agents Market Share, Trend Analytics and Forecast to 2023

Market Highlights:

There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, large number of surgical procedures across the globe are impacting the growth of the market positively. Increasing numbers of surgery procedures worldwide is one of another reason for driving the growth of the hemostasis and tissue sealing agents market.  Surgeries are performed by making cut on the body which leads to the wound formation.

The global Hemostasis and Tissue Sealing Agents Market is projected to grow at a CAGR of 8.6% over the forecast period.

There has been increasing demand for such products as it reduces complication during surgical procedures. Moreover, increase in road accidents across the globe is likely to increase the demand for hemostasis and tissue sealing agents. The wound formed as a result of accidents are uncovered to debris, soil, bodily fluids and microbes. Tissue is also lost during road accidents that rises the time for wound to heal. Increasing incidence of chronic injuries is among the major factors responsible for the growth of hemostasis and tissue sealing agents products market. Hemostasis and tissue sealing agents products, are used in assistant with surgical procedures to reduce the complexity during surgical procedures.

Key Players:

·         Johnson & Johnson

·         Cryolife

·         Baxter International

·         Ethicon LLC

·         Integra Lifesciences Corporation

·         Becton

·         Dickinson & Company

·         Cohera Medical

·         Pfizer

·         Medtronic plc

·         B. Braun Melsungen AG

·         MIL Laboratories Pvt

Segmentation:

·         The global hemostasis and tissue sealing agents market has been segmented into product, and end user.

·         By product, the market has been segmented into topical hemostats, and adhesive & tissue sealant. Furthermore, topical hemostats is divided into Active, mechanical (collagen based hemostats, cellulose based hemostats, gelatin based hemostats, polysaccharide based hemostats) Flowable. Adhesive & tissue sealant is further segmented into synthetic, natural, and adhesion barrier.

·         Further on the basis of end user the market is bifurcated into hospitals, ambulatory centers and others

Regional Analysis:

Geographically, the Americas is anticipated to dominate the global hemostasis and tissue sealing agents market owing to the high clinical R&D budgets by both government as well as public and private organizations, presence of major manufacturers for the products, high number of surgical procedures and various others. For instance, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the U.S.

Europe is expected to hold the second largest position in the global hemostasis and tissue sealing agents market. The Hemostasis and tissue sealing agents market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increased medical tourism for surgical procedures, increasing healthcare expenditure in developing countries and various others. The Middle East & Africa has the lowest share of the global hemostasis and tissue sealing agents market.

Healthcare Predictive Analytics Market Drivers, Global Analysis and Forecast to 2023

Market Overview:

Healthcare predictive analytics is generally used in the analysis of current data in order to predict future by using statistics, data mining, modeling, machine learning, and artificial intelligence. Increasing efficiency in the healthcare sector, the rising demand to curtail healthcare cost, and the advent of evidence-based and personalized medicine are some of the primary growth stimulants of the healthcare predictive analytics market. Rising importance of healthcare, especially in emerging nations is likely to generate new growth opportunities for the market in the foreseeable future.

Developing economies across the world are facing issues owing to the increasing medication cost. Governments are thus taking efforts to offer cost-effective services to the consumers at better quality. These efforts are likely to stimulate the predictive analytics market in the healthcare industry. The soaring demand for personalization for patient care, advancing technology, and rising awareness created by the top players are considered to encourage the market growth to a large extent.The global Healthcare Predictive Analytics Market is expected to exhibit a strong 29.3% CAGR over the forecast period (2018 to 2023), according to the latest research report from Market Research Future (MRFR).

Growing use of data-driven clinical decision support systems in the healthcare sector is likely to be a major driver for the global healthcare predictive analytics market over the forecast period. Clinical decision support systems are being welcomed in the healthcare sector around the world, as they provide the physician with a second layer of security, allowing more accurate diagnoses and better rehabilitation. Increasing applications of healthcare predictive analytics in population health management is also likely to be a major driver for the global healthcare predictive analytics market over the forecast period.

Competitive Analysis:

·         IBM

·         Verisk Analytics Inc.

·         Cerner Corporation

·         McKesson Corporation

·         Oracle

·         SAS

·         Allscripts

·         MedeAnalytics Inc

·         Optum Inc

·         Inovalon

·         SCIO Health Analytics

·         Health Catalyst

·         Verscend Technologies Inc.

·         Wipro Limited

·         CitiusTech Inc

Segmentation:

The global healthcare predictive analytics market report is segmented on the basis of application, end use, and component.

By application, the global healthcare predictive analytics market is segmented into operations management, financial, population health management, and clinical. The operations management segment is further sub-segmented into demand forecasting, workforce planning and scheduling, inpatient scheduling, and outpatient scheduling. The financial segment is further classified as revenue cycle management, fraud detection, and others. The population health segment is further sub-segmented as population risk management, patient engagement, population therapy management, and other applications. The clinical segment includes quality benchmarking, patient care enhancement, and clinical outcome analysis and management.

By end use, the global healthcare predictive analytics market is segmented into payers, providers, and others.

By component, the global healthcare predictive analytics market is segmented into services, software, and hardware.

Regional Analysis:

Healthcare predictive analytics is generally used in the analysis of current data in order to predict future by using statistics, data mining, modeling, machine learning, and artificial intelligence. Increasing efficiency in the healthcare sector, the rising demand to curtail healthcare cost, and the advent of evidence-based and personalized medicine are some of the primary growth stimulants of the healthcare predictive analytics market. Rising importance of healthcare, especially in emerging nations is likely to generate new growth opportunities for the market in the foreseeable future.

Developing economies across the world are facing issues owing to the increasing medication cost. Governments are thus taking efforts to offer cost-effective services to the consumers at better quality. These efforts are likely to stimulate the predictive analytics market in the healthcare industry. The soaring demand for personalization for patient care, advancing technology, and rising awareness created by the top players are considered to encourage the market growth to a large extent.

Transdermal Drug Delivery Systems Market Dynamics, Global Dynamics and Forecast to 2023

Introduction to TDDS:

The human skin is the largest organ of the human body. The skin covers a surface of nearly two square meters and receives nearly one-third of the blood in the body. Delivering drugs to the body through the skin has proved to be one of the most effective means of drug delivery besides oral delivery of drugs and therefore has received greater attention from the pharmaceutical industry due to increasing demand for controlled drug delivery. Skin is one of the most readily accessible organs of the human body. There is considerable interest in the skin as a site of drug application both for local and systemic effect, a factor that has added considerable interest to the transdermal drug delivery systems market.

The global Transdermal Drug Delivery Systems Market is expected to register a healthy CAGR over the forecast period. The market held a market value of USD 5,400.2 Million in 2017 and is projected to grow at a CAGR of 4.6% during the forecast period from 2018 to 2023.

Furthermore, the increasing occurrence of needle-stick injuries and growing uses of biologics are driving market growth. Substantial investments drawn in the R&D to develop advanced TDD systems are boosting the growth of the market, significantly. Additionally, spreading awareness, improving outcomes & patients’ experience, and beneficial reimbursement policies impact the market growth, positively for the transdermal drug delivery systems market which amassed nearly USD 5,400.2 million in 2017.

Benefits of TDDS:

The transdermal drug delivery systems market has been expanding due to various advantages of transdermal delivery circumventing the liver which can often prematurely metabolize drugs. Unlike hypodermic injections, transdermal deliveries are not painful, do not generate dangerous medical waste and are great for avoiding the risk of disease transmission by needle re-use which often a considerable risk factor in countries with impoverished healthcare facilities. Transdermal systems are non-invasive and can be self-administered, can provide release for long periods and have been known to improve patient compliance being generally inexpensive.

The limited number of drug available that can be transdermally administered is possibly one of the greatest challenges for the transdermal drug delivery systems market. This is because current delivery methods can only enable transdermal drugs that have molecular masses only up to a few hundred Daltons and require doses of milligrams per day or less. Therefore, transdermal delivery of peptides and macromolecules, hydrophilic drugs and novel genetic treatment that employ the use of DNA or small-interfering RNA are yet to be delivered through transdermal methods. Increasing investment in the transdermal drug delivery systems industry and tireless R&D that are aimed at enhancement of the

Regional Analysis:

North America dominates the global transdermal (percutaneous) drug delivery systems market with the largest market share. Factors such as the presence of major market players and developed healthcare infrastructure drive the growth of the regional market. Moreover, surging numbers of research activities related to transdermal drug delivery systems and comparatively higher adoption of TDD systems in the US and Canada impact the regional market growth, positively.

Besides, the highest GDP helps North America to have the edge over other regions in terms of every aspect, including healthcare and technology. Additionally, huge patient pool suffering from chronic diseases such as cardiovascular diseases alongside the presence of geriatric population and development in medical technology is supporting the growth of the market. The US, backed by the high per capita healthcare expenditures, contributes to the growth of the regional market, significantly.

Europe takes the second-leading position in the global transdermal drug delivery systems market. The phenomenal growth in the pharmaceutical industry and the presence of pharma giant companies such as Novartis International AG, Mylan N.V., Boehringer Ingelheim International GmbH, and Allergan plc., bolster the regional market growth. The resurging economy is playing a vital role in market development, allowing the proliferation of the healthcare sector in the region.

Germany, heading with its flourishing medical devices markets, hugely contributes to the growth of the regional market. Furthermore, the UK and France with the increasing investment in transdermal drug delivery systems drive the regional market at a large scale. The Europe TDDS market is estimated to register a phenomenal CAGR during the review period.

Healthcare Business Intelligence Market Highlights, Global Dynamics and Forecast to 2023

Market Overview:

The need to reach effective and profitable decisions in the business sector is essential to achieve growth. Reports that review the healthcare industry has been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities. The market is expected to tap into the favorable CAGR of 15.5 % in the course of the forecast period.

The need to observe current, historical and futuristic views of business operations is expected to motivate the healthcare business intelligence market. The benefit of financial, clinical, operational, and non-traditional data in making prudent decisions is the main factor promoting the healthcare business intelligence market. The presence of factors such as the appearance of big data in the healthcare industry, increasing demand to curb healthcare spending is expected to motivate the Healthcare Business Intelligence Market in the upcoming years.

On the other hand, the complexity of systems and the requirement of high investments are major constraints to the growth of this market. Nevertheless, cost-competitive deployment and effective features of healthcare business intelligence would support the growth of the market, widening its adoption increasingly. Also, the demand for cloud-based healthcare business intelligence has grown ominously due to cost-effective and easier classification features would bolster the growth of the market.

Competitive Analysis

The level of competitiveness of the environment in the market is expected to be reasonable as there is ample scope for progress. The market is anticipated to display positive signs for market growth in the approaching period. The demographic changes are expected to show a positive effect on the progress of the market. The surge in e-commerce activities is expected to motivate the market in the upcoming years. The fiscal policies that are in effect in the market are expected to lead to a robust pace of development. The leverage created by the companies by deploying marketing strategies and activities is further enhancing the expansion of the market. The enhancement of production facilities is expected to motivate the market’s progress. The trade liberalization in the market and technological developments are expected to encourage the development of the market in the approaching years.

Major Players:

·         Microsoft Corporation

·         International Business Machines Corporation

·         SAP SE

·         Oracle Corporation

·         SAS Institute

·         Tableau Software

·         MicroStrategy Incorporated

·         Qlik Technologies

·         Information Builders

·         Sisense

·         Yellowfin International Pty Ltd

·         BOARD International S.A.

Segmental Analysis

·         The segmental evaluation of the healthcare business intelligence market has been carried out on the basis of end-user, component, deployment model, function, application, and region.

·         Based on component, the healthcare business intelligence market has been segmented into software, platforms, and services.

·         Based on the function, the healthcare business intelligence market has been segmented into performance management, OLAP and visualization, and query and reporting. The segmentation of the healthcare business intelligence market based on application comprises of clinical analysis, financial analysis, and operational analysis. Based on the deployment model, the healthcare business intelligence market has been segmented into on-premise, hybrid, and cloud-based.

·         On the basis of end-user, the healthcare business intelligence market has been segmented into providers, payers, and others.

·         By region, the healthcare business intelligence market has been segmented into Europe, Asia-Pacific, the Americas, and the Middle East & Africa.

Detailed Regional Analysis   

North America leads the global healthcare business intelligence market with the largest market share. Factors such as the presence of leading software and service providers, availability of high-quality health services, and rising adoption of healthcare intelligence solutions & services by healthcare enterprises drive the regional market growth. Besides, intense research and development in the field of healthcare IT alongside, the evolving trends such as data proliferation, increasing competition, and cloud deployment foster the growth of the North American healthcare business intelligence market.

Europe takes the second leading position in the global healthcare business intelligence market. The rapid adoption of advanced medical technologies and growing healthcare industries in the region boost the growth of the market. Moreover, improved Internet connectivity, alongside the proliferation of the internet of things (IoT) devices impact the growth of the regional market. Furthermore, an increasing demand for predictive systems and electronic health record (EHR) software in the UK, Germany, France, and Spain are supporting the market growth in the region.

The Asia Pacific healthcare business intelligence market is rapidly emerging as a profitable market globally. Attributing to the increasing investment in the healthcare infrastructure, advancement in the algorithm, and developments in machine learning in the region, The APAC healthcare business intelligence market is expected to witness a flourishing growth over the forecast period.

Besides, the rising penetration of smartphones and the internet would fuel the growth of the regional market. Notably, Indian companies are shifting from traditional, tactical, and tool-centric data & analytical projects to strategic, state-of-the-art, and architecture-centric data & analytics programs, which, in turn, is assisting in the profitable growth of the regional market.

Veterinary Dental Equipment Market Insights, Current updates and Global Forecast to 2023

Veterinary Dental Equipment Market: Overview

The increasing rate of pet adoption in conjunction with rising pet care expenditure is expected to propel the expansion of the veterinary dental equipment market over the next couple of years. Injection of investments in the veterinary dental equipment market is anticipated to pave the way for innovations and advancements, thus, augmenting the market.

People are getting increasingly aware of the dental diseases prevailing among animals. It is expected to create a growth-inducing environment in the veterinary dental equipment market in the years to come. Also, the increasing burden of periodontal diseases is likely to favor the expansion of the market in the foreseeable future. On the flip side, the high cost of advanced equipment coupled with lack of skilled veterinarians is projected to impede the growth of the veterinary dental (dentistry) equipment market over the forecast period.The global Veterinary Dental Equipment Market   stood at a revenue of USD 312 million and to witness robust growth at a CAGR of 9.5% during the forecast period. This growth of the market is predicted on the back of the increasing prevalence of periodontal diseases in animals.

Veterinary Dental Equipment Market-Competitive Analysis:

·         Acteon Group

·         Cislak Manufacturing

·         Charles Brungart

·         Dentalaire

·         Eickemeyer

·         Dispomed

·         Henry Schein

·         Integra Lifescience

·         iM3 Pty Ltd

·         J & J Instruments

·         Midmark Corporation

·         MAI Animal Health

Segmentation:

·         The global veterinary dental equipment market is segmented based on product, end user, animal type, and region.

·         The global market for veterinary dental equipment, by product, is segmented into equipment, consumables, hand instruments, and others. Of these, the equipment segment is further segmented into dental lasers, electrosurgical units, dental x-ray systems, dental stations, and powered units.

·         By animal type, the market is segmented into companion animals, large animals, and others.

·         By end user, the market is segmented into veterinary clinics, veterinary hospitals, research & academic institutes, and others.

Regional Analysis:

The global veterinary dental equipment market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East and African (MEA). Americas has been projected to dominate the global market place trailed by Europe. The increasing expenditure in pet healthcare in these regional veterinary dental equipment markets is anticipated to revolutionize the growth pattern of the market across the assessment period.

Industry News:

In 2019, Midmark Corp. recently announced that the company has acquired Mason Company. Through this acquisition, the Midmark is looking to expand its product portfolio and its ability to work closely with our channel partners along with reach to their customers. Additionally, with architectural and design expertise of Mason, the company will improve its product for wellbeing of pets.